within Pharmacolibrary.Drugs.S_SensoryOrgans.S01G_DecongestantsAndAntiallergics.S01GX13_Bilastine;

model Bilastine
  extends Pharmacolibrary.Drugs.ATC.S.S01GX13;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01GX13</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Bilastine is a second-generation non-sedating antihistamine used for the treatment of allergic rhinoconjunctivitis and urticaria in adults and children over 12 years; it is approved and in clinical use today in Europe and other regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after oral administration of bilastine 20 mg as a single dose, under fasting conditions.</p><h4>References</h4><ol><li><p>Sádaba, B, et al., &amp; Valiente, R (2013). Oral availability of bilastine. <i>Clinical drug investigation</i> 33(5) 375–381. DOI:<a href=\"https://doi.org/10.1007/s40261-013-0076-y\">10.1007/s40261-013-0076-y</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23529786/\">https://pubmed.ncbi.nlm.nih.gov/23529786</a></p></li><li><p>Ochoa, D, et al., &amp; Fernández, N (2021). Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation. <i>Advances in therapy</i> 38(7) 4070–4081. DOI:<a href=\"https://doi.org/10.1007/s12325-021-01801-y\">10.1007/s12325-021-01801-y</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34125400/\">https://pubmed.ncbi.nlm.nih.gov/34125400</a></p></li><li><p>Majorek-Olechowska, B, et al., &amp; Arranz, P (2024). Pharmacokinetics and Safety of Bilastine 10 mg/d in Children Aged 2 to 5 Years With Allergic Rhinoconjunctivitis or Urticaria: A Phase 3 Clinical Trial. <i>Journal of investigational allergology &amp; clinical immunology</i> None 0–None. DOI:<a href=\"https://doi.org/10.18176/jiaci.1003\">10.18176/jiaci.1003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38725318/\">https://pubmed.ncbi.nlm.nih.gov/38725318</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Bilastine;
